- Tytuł :
- CXCL13: a novel biomarker of B-cell return following rituximab treatment and synovitis in patients with rheumatoid arthritis.
- Autorzy :
- Źródło :
- Rheumatology (Oxford, England) [Rheumatology (Oxford)] 2011 Mar; Vol. 50 (3), pp. 603-10. Date of Electronic Publication: 2010 Nov 23.
- Typ publikacji :
- Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
- MeSH Terms :
-
Antibodies, Monoclonal, Murine-Derived/*therapeutic use
Antirheumatic Agents/*therapeutic use
Arthritis, Rheumatoid/*blood
Chemokine CXCL13/*blood
Synovitis/*blood
Antibodies, Monoclonal, Murine-Derived/pharmacology ; Antirheumatic Agents/pharmacology ; Arthritis, Rheumatoid/drug therapy ; B-Lymphocytes/drug effects ; B-Lymphocytes/metabolism ; Biomarkers/blood ; Female ; Humans ; Male ; Predictive Value of Tests ; Rituximab ; Synovitis/drug therapy ; Treatment Outcome -
Czasopismo naukowe